---
document_datetime: 2023-09-21 20:23:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/emend-epar-all-authorised-presentations_en.pdf
document_name: emend-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1504176
conversion_datetime: 2025-12-20 00:24:59.651113
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength       | Pharmaceutical form        | Route of administration   | Immediate Packaging    | Pack size                                      |
|------------------|-------------------|----------------|----------------------------|---------------------------|------------------------|------------------------------------------------|
| EU/1/03/262/001  | Emend             | 80 mg          | Capsule, hard              | Oral use                  | blister (alu)          | 1 capsule                                      |
| EU/1/03/262/002  | Emend             | 80 mg          | Capsule, hard              | Oral use                  | blister (alu)          | 2 capsules                                     |
| EU/1/03/262/003  | Emend             | 80 mg          | Capsule, hard              | Oral use                  | blister (alu)          | 5 x 1 capsule                                  |
| EU/1/03/262/004  | Emend             | 125 mg         | Capsule, hard              | Oral use                  | blister (alu)          | 1 capsule                                      |
| EU/1/03/262/005  | Emend             | 125 mg         | Capsule, hard              | Oral use                  | blister (alu)          | 5 x 1 capsule                                  |
| EU/1/03/262/006  | Emend             | 125 mg + 80 mg | Capsule, hard              | Oral use                  | blister (alu)          | 1 capsule (125 mg) + 2 capsules (80 mg)        |
| EU/1/03/262/011  | Emend             | 125 mg         | Powder for oral suspension | Oral use                  | Sachet (PET/Alu/LLDPE) | 1 sachet + 2 dispensers + 1 cap + 1 mixing cup |